Activist investor William Ackman's Pershing Square Capital
Management LP on Monday put forth a slate of six nominees for Botox
maker Allergan Inc.'s board.
Pershing has backed Valeant Pharmaceuticals International Inc.'s
roughly $53 billion takeover bid for Allergan, which has rejected a
series of offers from Valeant. Pershing owns a 9.7% stake in
Allergan.
Pershing and Allergan agreed last month to a deal that allows
Mr. Ackman and his firm to coordinate with shareholders to call a
special meeting.
Last week, the Valeant bid received a vote of confidence from
Credit Suisse Group AG as the bank agreed to advise Pershing in the
Allergan bid.
Pershing's slate includes Betsy Atkins, Cathleen P. Black,
Fredric N. Eshelman, Steven J. Shulman, David A. Wilson and John J.
Zillmer. Pershing said the nominees are independent of Pershing and
Valeant.
An Allergan representative didn't immediately respond to a
request for comment.
Write to Michael Calia at michael.calia@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires